215 related articles for article (PubMed ID: 12000758)
1. Recombinant MUC1 probe authentically reflects cell-specific O-glycosylation profiles of endogenous breast cancer mucin. High density and prevalent core 2-based glycosylation.
Müller S; Hanisch FG
J Biol Chem; 2002 Jul; 277(29):26103-12. PubMed ID: 12000758
[TBL] [Abstract][Full Text] [Related]
2. Transmembrane and secreted MUC1 probes show trafficking-dependent changes in O-glycan core profiles.
Engelmann K; Kinlough CL; Müller S; Razawi H; Baldus SE; Hughey RP; Hanisch FG
Glycobiology; 2005 Nov; 15(11):1111-24. PubMed ID: 15972891
[TBL] [Abstract][Full Text] [Related]
3. Recombinant MUC1 mucin with a breast cancer-like O-glycosylation produced in large amounts in Chinese-hamster ovary cells.
Bäckström M; Link T; Olson FJ; Karlsson H; Graham R; Picco G; Burchell J; Taylor-Papadimitriou J; Noll T; Hansson GC
Biochem J; 2003 Dec; 376(Pt 3):677-86. PubMed ID: 12950230
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms underlying aberrant glycosylation of MUC1 mucin in breast cancer cells.
Brockhausen I; Yang JM; Burchell J; Whitehouse C; Taylor-Papadimitriou J
Eur J Biochem; 1995 Oct; 233(2):607-17. PubMed ID: 7588808
[TBL] [Abstract][Full Text] [Related]
5. The O-linked glycosylation of secretory/shed MUC1 from an advanced breast cancer patient's serum.
Storr SJ; Royle L; Chapman CJ; Hamid UM; Robertson JF; Murray A; Dwek RA; Rudd PM
Glycobiology; 2008 Jun; 18(6):456-62. PubMed ID: 18332077
[TBL] [Abstract][Full Text] [Related]
6. MUC1 glycoforms in breast cancer--cell line T47D as a model for carcinoma-associated alterations of 0-glycosylation.
Hanisch FG; Stadie TR; Deutzmann F; Peter-Katalinic J
Eur J Biochem; 1996 Feb; 236(1):318-27. PubMed ID: 8617281
[TBL] [Abstract][Full Text] [Related]
7. High density O-glycosylation on tandem repeat peptide from secretory MUC1 of T47D breast cancer cells.
Müller S; Alving K; Peter-Katalinic J; Zachara N; Gooley AA; Hanisch FG
J Biol Chem; 1999 Jun; 274(26):18165-72. PubMed ID: 10373415
[TBL] [Abstract][Full Text] [Related]
8. MUC1 and cancer.
Taylor-Papadimitriou J; Burchell J; Miles DW; Dalziel M
Biochim Biophys Acta; 1999 Oct; 1455(2-3):301-13. PubMed ID: 10571020
[TBL] [Abstract][Full Text] [Related]
9. The ST6GalNAc-I sialyltransferase localizes throughout the Golgi and is responsible for the synthesis of the tumor-associated sialyl-Tn O-glycan in human breast cancer.
Sewell R; Bäckström M; Dalziel M; Gschmeissner S; Karlsson H; Noll T; Gätgens J; Clausen H; Hansson GC; Burchell J; Taylor-Papadimitriou J
J Biol Chem; 2006 Feb; 281(6):3586-94. PubMed ID: 16319059
[TBL] [Abstract][Full Text] [Related]
10. Evidence for core 2 to core 1 O-glycan remodeling during the recycling of MUC1.
Razawi H; Kinlough CL; Staubach S; Poland PA; Rbaibi Y; Weisz OA; Hughey RP; Hanisch FG
Glycobiology; 2013 Aug; 23(8):935-45. PubMed ID: 23640779
[TBL] [Abstract][Full Text] [Related]
11. Diverse glycosylation of MUC1 and MUC2: potential significance in tumor immunity.
Irimura T; Denda K; Iida Si; Takeuchi H; Kato K
J Biochem; 1999 Dec; 126(6):975-85. PubMed ID: 10578046
[TBL] [Abstract][Full Text] [Related]
12. A transfected sialyltransferase that is elevated in breast cancer and localizes to the medial/trans-Golgi apparatus inhibits the development of core-2-based O-glycans.
Whitehouse C; Burchell J; Gschmeissner S; Brockhausen I; Lloyd KO; Taylor-Papadimitriou J
J Cell Biol; 1997 Jun; 137(6):1229-41. PubMed ID: 9182658
[TBL] [Abstract][Full Text] [Related]
13. Sialylated core 1 based O-linked glycans enhance the growth rate of mammary carcinoma cells in MUC1 transgenic mice.
Mungul A; Cooper L; Brockhausen I; Ryder K; Mandel U; Clausen H; Rughetti A; Miles DW; Taylor-Papadimitriou J; Burchell JM
Int J Oncol; 2004 Oct; 25(4):937-43. PubMed ID: 15375543
[TBL] [Abstract][Full Text] [Related]
14. N-Glycosylation of the MUC1 mucin in epithelial cells and secretions.
Parry S; Hanisch FG; Leir SH; Sutton-Smith M; Morris HR; Dell A; Harris A
Glycobiology; 2006 Jul; 16(7):623-34. PubMed ID: 16585136
[TBL] [Abstract][Full Text] [Related]
15. A MUC1 tandem repeat reporter protein produced in CHO-K1 cells has sialylated core 1 O-glycans and becomes more densely glycosylated if coexpressed with polypeptide-GalNAc-T4 transferase.
Olson FJ; Bäckström M; Karlsson H; Burchell J; Hansson GC
Glycobiology; 2005 Feb; 15(2):177-91. PubMed ID: 15456735
[TBL] [Abstract][Full Text] [Related]
16. MUC1 in human and murine mammary carcinoma cells decreases the expression of core 2 β1,6-N-acetylglucosaminyltransferase and β-galactoside α2,3-sialyltransferase.
Solatycka A; Owczarek T; Piller F; Piller V; Pula B; Wojciech L; Podhorska-Okolow M; Dziegiel P; Ugorski M
Glycobiology; 2012 Aug; 22(8):1042-54. PubMed ID: 22534569
[TBL] [Abstract][Full Text] [Related]
17. Top-down sequencing of O-glycoproteins by in-source decay matrix-assisted laser desorption ionization mass spectrometry for glycosylation site analysis.
Hanisch FG
Anal Chem; 2011 Jun; 83(12):4829-37. PubMed ID: 21526855
[TBL] [Abstract][Full Text] [Related]
18. Site directed processing: role of amino acid sequences and glycosylation of acceptor glycopeptides in the assembly of extended mucin type O-glycan core 2.
Brockhausen I; Dowler T; Paulsen H
Biochim Biophys Acta; 2009 Oct; 1790(10):1244-57. PubMed ID: 19524017
[TBL] [Abstract][Full Text] [Related]
19. O-linked mucin-type glycosylation regulates the transcriptional programme downstream of EGFR.
Tajadura-Ortega V; Gambardella G; Skinner A; Halim A; Van Coillie J; Schjoldager KTG; Beatson R; Graham R; Achkova D; Taylor-Papadimitriou J; Ciccarelli FD; Burchell JM
Glycobiology; 2021 Apr; 31(3):200-210. PubMed ID: 32776095
[TBL] [Abstract][Full Text] [Related]
20. The relative activities of the C2GnT1 and ST3Gal-I glycosyltransferases determine O-glycan structure and expression of a tumor-associated epitope on MUC1.
Dalziel M; Whitehouse C; McFarlane I; Brockhausen I; Gschmeissner S; Schwientek T; Clausen H; Burchell JM; Taylor-Papadimitriou J
J Biol Chem; 2001 Apr; 276(14):11007-15. PubMed ID: 11118434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
